Evidence map›Paper›PMID 29240831›Full record

ArticlePLoS pathogens2017

Comparative transcriptome profiling of virulent and non-virulent Trypanosoma cruzi underlines the role of surface proteins during infection.

A Trey Belew, Caroline Junqueira, Gabriela F Rodrigues-Luiz, Bruna M Valente, Antonio Edson R Oliveira, Rafael B Polidoro, Luciana W Zuccherato, Daniella C Bartholomeu, Sergio Schenkman, Ricardo T Gazzinelli and 3 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 69 citations in OpenAlex.

  1. Revisiting cysteine protease function inMicrobiology spectrum · 2026
    Article
  2. Article
  3. Mitochondrial DNA Structure inPathogens (Basel, Switzerland) · 2025
    Review
  4. The 50th Anniversary Conference - Caxambu 2024.Memorias do Instituto Oswaldo Cruz · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Role of a 49 kDaPathogens (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Review
  13. Modulation of Virulence Factors duringPathogens (Basel, Switzerland) · 2022
    Review
  14. Article
  15. The Use of AlphaFold forFrontiers in cellular and infection microbiology · 2022
    Article
  16. An induced population ofFrontiers in cellular and infection microbiology · 2022
    Article
  17. Frontiers in cellular and infection microbiology · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

A Trey BelewDepartment of Cell Biology and Molecular Genetics and Center for Bioinformatics and Computational Biology, University of Maryland, College Park, Maryland, United States of America.
Caroline JunqueiraCentro de Pesquisas Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.
Gabriela F Rodrigues-LuizDepartamento de Parasitologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0003-3838-1008
Bruna M ValenteDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Antonio Edson R OliveiraDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Rafael B PolidoroDepartmento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0003-2982-0072
Luciana W ZuccheratoDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Daniella C BartholomeuDepartamento de Parasitologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Sergio SchenkmanDepartmento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0001-9353-8480
Ricardo T GazzinelliCentro de Pesquisas Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.
Barbara A BurleighDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Najib M El-SayedDepartment of Cell Biology and Molecular Genetics and Center for Bioinformatics and Computational Biology, University of Maryland, College Park, Maryland, United States of America.ORCID 0000-0001-7970-3312
Santuza M R TeixeiraDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0002-2588-2842
Universidade Federal de Minas Gerais · BRUniversidade Federal de São Paulo · BRUniversity of Maryland, College Park · USFundação Oswaldo Cruz · BRHarvard University · US

Funding

Profiling the Leishmania-macrophage Host-pathogen InfectomeR01AI094773 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI EL-SAYED, NAJIB M, MOSSER, DAVID M · 2011 to 2014
$2.5M
Transcriptome profiling of Trypanosoma cruzi and its host cellR21AI094195 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI BURLEIGH, BARBARA A, EL-SAYED, NAJIB M · 2011 to 2012
$445k
NIAID NIH HHS R01 AI094773NIAID NIH HHS R21 AI094195
6 · The paper itself

Abstract

Trypanosoma cruzi, the protozoan that causes Chagas disease, has a complex life cycle involving several morphologically and biochemically distinct stages that establish intricate interactions with various insect and mammalian hosts. It has also a heterogeneous population structure comprising strains with distinct properties such as virulence, sensitivity to drugs, antigenic profile and tissue tropism. We present a comparative transcriptome analysis of two cloned T. cruzi strains that display contrasting virulence phenotypes in animal models of infection: CL Brener is a virulent clone and CL-14 is a clone that is neither infective nor pathogenic in in vivo models of infection. Gene expression analysis of trypomastigotes and intracellular amastigotes harvested at 60 and 96 hours post-infection (hpi) of human fibroblasts revealed large differences that reflect the parasite's adaptation to distinct environments during the infection of mammalian cells, including changes in energy sources, oxidative stress responses, cell cycle control and cell surface components. While extensive transcriptome remodeling was observed when trypomastigotes of both strains were compared to 60 hpi amastigotes, differences in gene expression were much less pronounced when 96 hpi amastigotes and trypomastigotes of CL Brener were compared. In contrast, the differentiation of the avirulent CL-14 from 96 hpi amastigotes to extracellular trypomastigotes was associated with considerable changes in gene expression, particularly in gene families encoding surface proteins such as trans-sialidases, mucins and the mucin associated surface proteins (MASPs). Thus, our comparative transcriptome analysis indicates that the avirulent phenotype of CL-14 may be due, at least in part, to a reduced or delayed expression of genes encoding surface proteins that are associated with the transition of amastigotes to trypomastigotes, an essential step in the establishment of the infection in the mammalian host. Confirming the role of members of the trans-sialidase family of surface proteins for parasite differentiation, transfected CL-14 constitutively expressing a trans-sialidase gene displayed faster kinetics of trypomastigote release in the supernatant of infected cells compared to wild type CL-14.

Indexed as

AnimalsChagas DiseaseGene Expression ProfilingGene Expression Regulation, DevelopmentalGene OntologyGenes, ProtozoanGlycoproteinsHost-Parasite InteractionsHumansMembrane ProteinsMiceMice, Inbred BALB CNeuraminidaseProtozoan ProteinsRNA-Binding ProteinsTrypanosoma cruziGlycoproteinsMembrane ProteinsNeuraminidaseProtozoan ProteinsRNA-Binding Proteinstrans-sialidase

Identifiers

PMID29240831
PMCPMC5746284
OpenAlexW2772141281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.